Medistim ASA (MEDI.OL)
NOK 161.0
(1.58%)
NOK 161.0
(1.58%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 9.26 Million NOK | -7.58% |
| 2022 | 10.02 Million NOK | -41.33% |
| 2021 | 17.07 Million NOK | -41.57% |
| 2020 | 29.23 Million NOK | 7.54% |
| 2019 | 27.18 Million NOK | 262.44% |
| 2018 | 7.5 Million NOK | -28.57% |
| 2017 | 10.5 Million NOK | 460.0% |
| 2016 | 1.87 Million NOK | -66.67% |
| 2015 | 5.62 Million NOK | -49.05% |
| 2014 | 11.04 Million NOK | 121.7% |
| 2013 | 4.98 Million NOK | 0.0% |
| 2012 | - NOK | 0.0% |
| 2011 | - NOK | 0.0% |
| 2010 | - NOK | -100.0% |
| 2009 | 3 Million NOK | -57.12% |
| 2008 | 7 Million NOK | -38.67% |
| 2007 | 11.42 Million NOK | 0.0% |
| 2006 | - NOK | 0.0% |
| 2005 | - NOK | 0.0% |
| 2004 | - NOK | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 9.1 Million NOK | 0.0% |
| 2024 Q3 | - NOK | 0.0% |
| 2024 Q2 | 10.32 Million NOK | 0.0% |
| 2023 Q3 | 4.15 Million NOK | -34.84% |
| 2023 Q1 | 8.02 Million NOK | -19.91% |
| 2023 Q2 | 6.36 Million NOK | -20.64% |
| 2023 FY | 9.26 Million NOK | -7.58% |
| 2023 Q4 | 9.26 Million NOK | 123.13% |
| 2022 Q2 | 13.5 Million NOK | -11.7% |
| 2022 FY | 10.02 Million NOK | -41.33% |
| 2022 Q3 | 13.5 Million NOK | 0.0% |
| 2022 Q4 | 10.02 Million NOK | -25.78% |
| 2022 Q1 | 15.29 Million NOK | -10.47% |
| 2021 Q3 | 18.18 Million NOK | -6.66% |
| 2021 Q2 | 19.48 Million NOK | -28.05% |
| 2021 Q4 | 17.07 Million NOK | -6.09% |
| 2021 Q1 | 27.07 Million NOK | -7.37% |
| 2021 FY | 17.07 Million NOK | -41.57% |
| 2020 Q1 | 24.93 Million NOK | -8.27% |
| 2020 Q2 | 22.68 Million NOK | -9.01% |
| 2020 Q3 | 30.65 Million NOK | 35.12% |
| 2020 Q4 | 29.23 Million NOK | -4.65% |
| 2020 FY | 29.23 Million NOK | 7.54% |
| 2019 Q2 | 7.55 Million NOK | -1.33% |
| 2019 Q3 | 6.92 Million NOK | -8.32% |
| 2019 Q4 | 27.18 Million NOK | 292.31% |
| 2019 FY | 27.18 Million NOK | 262.44% |
| 2019 Q1 | 7.66 Million NOK | 2.13% |
| 2018 Q1 | 8.81 Million NOK | -16.07% |
| 2018 Q4 | 7.5 Million NOK | -9.09% |
| 2018 Q2 | 8.06 Million NOK | -8.51% |
| 2018 Q3 | 8.25 Million NOK | 2.32% |
| 2018 FY | 7.5 Million NOK | -28.57% |
| 2017 FY | 10.5 Million NOK | 460.0% |
| 2017 Q4 | 10.5 Million NOK | -6.67% |
| 2017 Q3 | 11.25 Million NOK | -6.25% |
| 2017 Q2 | 12 Million NOK | 0.0% |
| 2017 Q1 | - NOK | -100.0% |
| 2016 Q3 | 3.66 Million NOK | -2.29% |
| 2016 FY | 1.87 Million NOK | -66.67% |
| 2016 Q2 | 3.75 Million NOK | -32.08% |
| 2016 Q4 | 1.87 Million NOK | -48.83% |
| 2016 Q1 | 5.52 Million NOK | -1.87% |
| 2015 FY | 5.62 Million NOK | -49.05% |
| 2015 Q1 | 9.27 Million NOK | -16.04% |
| 2015 Q2 | 9.22 Million NOK | -0.5% |
| 2015 Q3 | 5.73 Million NOK | -37.88% |
| 2015 Q4 | 5.62 Million NOK | -1.83% |
| 2014 Q3 | 12.79 Million NOK | -12.16% |
| 2014 Q1 | 4.14 Million NOK | -16.72% |
| 2014 FY | 11.04 Million NOK | 121.7% |
| 2014 Q4 | 11.04 Million NOK | -13.69% |
| 2014 Q2 | 14.56 Million NOK | 251.13% |
| 2013 Q4 | 4.98 Million NOK | -45.54% |
| 2013 Q2 | 9.98 Million NOK | 0.0% |
| 2013 Q1 | - NOK | 0.0% |
| 2013 FY | 4.98 Million NOK | 0.0% |
| 2013 Q3 | 9.14 Million NOK | -8.35% |
| 2012 Q2 | - NOK | 0.0% |
| 2012 Q1 | - NOK | 0.0% |
| 2012 Q3 | - NOK | 0.0% |
| 2012 FY | - NOK | 0.0% |
| 2012 Q4 | - NOK | 0.0% |
| 2011 Q2 | - NOK | 0.0% |
| 2011 Q4 | - NOK | 0.0% |
| 2011 FY | - NOK | 0.0% |
| 2011 Q1 | - NOK | 0.0% |
| 2011 Q3 | - NOK | 0.0% |
| 2010 FY | - NOK | -100.0% |
| 2010 Q3 | - NOK | 0.0% |
| 2010 Q2 | - NOK | 0.0% |
| 2010 Q1 | - NOK | -100.0% |
| 2010 Q4 | - NOK | 0.0% |
| 2009 FY | 3 Million NOK | -57.12% |
| 2009 Q4 | 3 Million NOK | 0.0% |
| 2008 FY | 7 Million NOK | -38.67% |
| 2007 FY | 11.42 Million NOK | 0.0% |
| 2006 FY | - NOK | 0.0% |
| 2005 FY | - NOK | 0.0% |
| 2004 FY | - NOK | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Gentian Diagnostics ASA | 9 Million NOK | -2.82% |
| Lifecare AS | 7.66 Million NOK | -20.873% |